Amiloidózis: vizsgálatok itt: Törökország

3 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  Where

  Ankara, Antalya, Istanbul

  Életkor

  18 év to 85 év

  People

  1750 worldwide

  Run by

  Alnylam Pharmaceuticals

  See details and how to joinNCT07052903 · EU 2024-519917-72-00
• 3. fázisTaking people
  TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

  Where

  Istanbul, Izmir

  Életkor

  18 év to 85 év

  People

  125 worldwide

  Run by

  Alnylam Pharmaceuticals

  See details and how to joinNCT07223203 · EU 2025-522544-40-00
• 3. fázisNot yet taking people in Törökország
  An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy

  Where

  Dinar, Eskişehir, Istanbul, Mersin

  People

  1180 worldwide

  Run by

  Alexion Pharmaceuticals, Inc.

  See details and how to joinNCT07789483 · EU 2026-526755-57-00